Intestinal Microbiota—A Promising Target for Antiviral Therapy?
نویسندگان
چکیده
منابع مشابه
Cucurbitacins - a promising target for cancer therapy.
During the last decades a large number of cucurbitacins have been isolated from various plant species belonging to other plant families than Cucurbitaceae. Although the roots and the fruits of plant belong to these Cucurbitaceae species are very bitter, they have been used as folk medicines in some countries because of their wide spectrum of pharmacological activities such as anti-inflammation ...
متن کاملKinetoplast DNA: A Promising Drug Target for Treatment of Leishmaniasis
Leishmaniasis is a vector-borne zoonotic disease caused by various species of the genus Leishmania, (trypanosomatidae family) that is transmitted by phlebotomine sandflies. The disease can present in a range of clinical forms, including dermal lesions, metastasis mucocutaneous forms, and fatal visceral forms. In this non-systematic review, we aimed at introducing the role of kinetoplast DNA (kD...
متن کاملRNA interference: a promising approach to antiviral therapy?
RNA interference (RNAi) has developed into a powerful tool for probing gene function. Recently, several reports have demonstrated the use of RNAi for attenuation of viral infection and replication in cultured cells. Furthermore, RNAi has been shown to suppress gene expression in adult animals. Although these results suggest that RNAi might become a novel therapeutic approach, significant hurdle...
متن کاملFucosylation Is a Promising Target for Cancer Diagnosis and Therapy
Oligosaccharides, sequences of carbohydrates conjugated to proteins and lipids, are arguably the most abundant and structurally diverse class of molecules. Fucosylation is one of the most important oligosaccharide modifications involved in cancer and inflammation. Recent advances in glycomics have identified several types of glyco-biomarkers containing fucosylation that are linked to certain ty...
متن کاملDengue Virus Entry as Target for Antiviral Therapy
Dengue virus (DENV) infections are expanding worldwide and, because of the lack of a vaccine, the search for antiviral products is imperative. Four serotypes of DENV are described and they all cause a similar disease outcome. It would be interesting to develop an antiviral product that can interact with all four serotypes, prevent host cell infection and subsequent immune activation. DENV entry...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Immunology
سال: 2021
ISSN: 1664-3224
DOI: 10.3389/fimmu.2021.676232